Recent CDC data confirming a record-low U.S. general fertility rate of 53.1 births per 1,000 women ages 15–44 in 2025—down 1% from 2024 and 23% since the 2007 peak—has anchored trader sentiment against any Q1 2026 rebound. Preliminary January and February birth figures showing year-over-year drops of 4.8% and 2.15% respectively reinforce the long-running pattern of delayed childbearing, economic pressures, and below-replacement trends that define the current landscape. With the Q4 2025 benchmark at 53.3 and no reversal signals in early monthly releases, the market’s strong “No” consensus reflects these sustained demographic headwinds ahead of the next Vital Statistics Rapid Release.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · ОбновленоUS fertility rate up in Q1 2026?
НОВОЕ
НОВОЕ
31 дек. 2026 г.
НОВОЕ
НОВОЕ
31 дек. 2026 г.
The CDC estimates a general fertility rate of 53.3 births per 1,000 women aged 15–44 for Q4 2025 (see: https://www.cdc.gov/nchs/nvss/vsrr/natality-dashboard.htm).
This market will resolve to "Yes" if the initial reported rate for Q1 2026 exceeds 53.3, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No".
If the CDC does not release general fertility rate data for Q1 2026 by March 31, 2027, 11:59 PM ET, this market will resolve to "No".
Resolution will be based on the first published estimate for Q1 2026, regardless of any subsequent revisions.
The resolution source will be the CDC’s Vital Statistics Rapid Release.Recent CDC data confirming a record-low U.S. general fertility rate of 53.1 births per 1,000 women ages 15–44 in 2025—down 1% from 2024 and 23% since the 2007 peak—has anchored trader sentiment against any Q1 2026 rebound. Preliminary January and February birth figures showing year-over-year drops of 4.8% and 2.15% respectively reinforce the long-running pattern of delayed childbearing, economic pressures, and below-replacement trends that define the current landscape. With the Q4 2025 benchmark at 53.3 and no reversal signals in early monthly releases, the market’s strong “No” consensus reflects these sustained demographic headwinds ahead of the next Vital Statistics Rapid Release.
The CDC estimates a general fertility rate of 53.3 births per 1,000 women aged 15–44 for Q4 2025 (see: https://www.cdc.gov/nchs/nvss/vsrr/natality-dashboard.htm).
This market will resolve to "Yes" if the initial reported rate for Q1 2026 exceeds 53.3, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No".
If the CDC does not release general fertility rate data for Q1 2026 by March 31, 2027, 11:59 PM ET, this market will resolve to "No".
Resolution will be based on the first published estimate for Q1 2026, regardless of any subsequent revisions.
The resolution source will be the CDC’s Vital Statistics Rapid Release.
This market will resolve to "Yes" if the initial reported rate for Q1 2026 exceeds 53.3, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No".
If the CDC does not release general fertility rate data for Q1 2026 by March 31, 2027, 11:59 PM ET, this market will resolve to "No".
Resolution will be based on the first published estimate for Q1 2026, regardless of any subsequent revisions.
The resolution source will be the CDC’s Vital Statistics Rapid Release.
Открытие рынка: Apr 27, 2026, 4:53 PM ET
Объем
$73Дата окончания
31 дек. 2026 г.Открытие рынка
Apr 27, 2026, 4:53 PM ETResolver
0x65070BE91...The CDC estimates a general fertility rate of 53.3 births per 1,000 women aged 15–44 for Q4 2025 (see: https://www.cdc.gov/nchs/nvss/vsrr/natality-dashboard.htm).
This market will resolve to "Yes" if the initial reported rate for Q1 2026 exceeds 53.3, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No".
If the CDC does not release general fertility rate data for Q1 2026 by March 31, 2027, 11:59 PM ET, this market will resolve to "No".
Resolution will be based on the first published estimate for Q1 2026, regardless of any subsequent revisions.
The resolution source will be the CDC’s Vital Statistics Rapid Release.Recent CDC data confirming a record-low U.S. general fertility rate of 53.1 births per 1,000 women ages 15–44 in 2025—down 1% from 2024 and 23% since the 2007 peak—has anchored trader sentiment against any Q1 2026 rebound. Preliminary January and February birth figures showing year-over-year drops of 4.8% and 2.15% respectively reinforce the long-running pattern of delayed childbearing, economic pressures, and below-replacement trends that define the current landscape. With the Q4 2025 benchmark at 53.3 and no reversal signals in early monthly releases, the market’s strong “No” consensus reflects these sustained demographic headwinds ahead of the next Vital Statistics Rapid Release.
The CDC estimates a general fertility rate of 53.3 births per 1,000 women aged 15–44 for Q4 2025 (see: https://www.cdc.gov/nchs/nvss/vsrr/natality-dashboard.htm).
This market will resolve to "Yes" if the initial reported rate for Q1 2026 exceeds 53.3, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No".
If the CDC does not release general fertility rate data for Q1 2026 by March 31, 2027, 11:59 PM ET, this market will resolve to "No".
Resolution will be based on the first published estimate for Q1 2026, regardless of any subsequent revisions.
The resolution source will be the CDC’s Vital Statistics Rapid Release.
This market will resolve to "Yes" if the initial reported rate for Q1 2026 exceeds 53.3, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No".
If the CDC does not release general fertility rate data for Q1 2026 by March 31, 2027, 11:59 PM ET, this market will resolve to "No".
Resolution will be based on the first published estimate for Q1 2026, regardless of any subsequent revisions.
The resolution source will be the CDC’s Vital Statistics Rapid Release.
Объем
$73Дата окончания
31 дек. 2026 г.Открытие рынка
Apr 27, 2026, 4:53 PM ETResolver
0x65070BE91...Recent CDC data confirming a record-low U.S. general fertility rate of 53.1 births per 1,000 women ages 15–44 in 2025—down 1% from 2024 and 23% since the 2007 peak—has anchored trader sentiment against any Q1 2026 rebound. Preliminary January and February birth figures showing year-over-year drops of 4.8% and 2.15% respectively reinforce the long-running pattern of delayed childbearing, economic pressures, and below-replacement trends that define the current landscape. With the Q4 2025 benchmark at 53.3 and no reversal signals in early monthly releases, the market’s strong “No” consensus reflects these sustained demographic headwinds ahead of the next Vital Statistics Rapid Release.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы